Global Spatial Omics Market to reach USD 1,308.88 million by 2032 with significant growth potential.
From GlobeNewswire: 2025-05-23 09:35:00
The global Spatial Omics Market was valued at USD 451.76 million in 2023, projected to reach USD 1,308.88 million by 2032 with a CAGR of 12.55%. The US dominated in 2023, accounting for over 81% of the market share, driven by precision medicine demand and detailed molecular tissue-level insights, especially in oncology and neuroscience.
Spatial omics integrates genomics, transcriptomics, and proteomics with spatial data at the single-cell level. The US academic and biopharma sectors are heavily investing in spatial biology tools for drug discovery and personalized treatments, revolutionizing disease investigation and treatment methods.
Key players in the Spatial Omics Market include Illumina, Bio-Techne, and NanoString Technologies. Consumables led in 2023, with instruments showing rapid growth potential. FFPE samples dominated at 60.7%, while spatial transcriptomics led technology market share at 40.9%, with diagnostics as the top application.
In 2023, North America held the largest share of the global market at 39.7%, driven by early technology adoption and R&D funding. Asia Pacific is a promising region due to government investments in spatial biology research, while Europe, particularly Germany and the UK, is focusing on cancer and neurodegenerative disease research.
Illumina unveiled a spatial transcriptomics tech in February 2025, offering high-resolution cell mapping capabilities. The new system can resolve millions of cells per experiment with higher resolution, signaling advancements in spatial omics technology. In January 2025, University of Pennsylvania researchers introduced an AI tool called MISO for personalized cancer diagnostics. 10x Genomics introduced the Xenium Analyzer Plus in December 2024 for RNA and protein detection. In November 2024, NanoString Technologies and Thermo Fisher Scientific partnered for spatial multi-omic panels. Globally, over USD 1.5 billion was invested in spatial biology research, with North America contributing approximately 48%. 27% of new oncology trials in 2023 included spatial omics data, a 60% increase from 2020. The US leads in trial-based adoption. Adoption of spatial omics in academic labs is estimated to increase 4-fold by 2032. Spatial transcriptomics and proteomics produced over 1.2 petabytes of data in 2023, with more than 65% analyzed in the cloud. The cost of a spatial omics operation decreased to USD 480 per sample in 2023 and is expected to drop below USD 300 in 2027 through automation and standardization.
The Spatial Omics Market is segmented by product, sample type, technology, application, workflow, and end-use. Products include instruments and consumables. Sample types include FFPE and fresh frozen. Technologies encompass spatial transcriptomics, genomics, and proteomics. Applications span diagnostics, translation research, cell biology, and single cell analysis. Workflows cover sample preparation, instrumental analysis, and data analysis. End-users include academic research institutes, pharmaceutical companies, CROs, and others.
For more information on the Spatial Omics Market and customization research, visit the provided link. The market report includes an introduction, executive summary, research methodology, impact analysis, trends reporting, competitive landscape, market segmentation by product, sample type, technology, application, workflow, and end-use, regional analysis, company profiles, use cases, best practices, and conclusion. Related reports on the Single-Cell Analysis Market, Single-Cell Omics Market, Consumer Genomics Market, and Bioinformatics Market are also available for reference. SNS Insider is a leading market research and consulting agency providing up-to-date market data, consumer insights, and opinions to help clients make informed decisions confidently.
Read more at GlobeNewswire: Spatial Omics Market Set to Reach USD 1,308.88 Million by